25-Hydroxyvitamin D Measurement, 2009: A Review for Clinicians

Journal of Clinical Densitometry

Volumn 12, Issue 4, 2009, Pages 417-427

  Binkley, Neil ^a   Krueger, Diane ^a   Lensmeyer, Gary ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

25(OH)D; Measurement; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; COLECALCIFEROL; ERGOCALCIFEROL;

ELECTROCHEMICAL DETECTION; EVIDENCE BASED PRACTICE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYDROPHOBICITY; IMMUNOCHEMISTRY; PRIORITY JOURNAL; PROTEIN BINDING; REVIEW; SOLID PHASE EXTRACTION; TANDEM MASS SPECTROMETRY; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION;

CHROMATOGRAPHY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMANS; MASS SCREENING; MORBIDITY; REPRODUCIBILITY OF RESULTS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 70449115579     PISSN: 10946950     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jocd.2009.06.001     Document Type: Review

References (72)

1. Holick M.F. Environmental factors that influence the cutaneous production of vitamin D. Am J Clin Nutr 61 3 Suppl (1995) 638S-645S
2. Holick M.F. The photobiology of vitamin D and its consequences for humans. Ann N Y Acad Sci 453 (1985) 1-13
3. Looker A.C., Dawson-Hughes B., Calvo M.S., et al. Serum 25-hydroxyvitamin D status of adolescents and adults in two seasonal subpopulations from NHANES III. Bone 30 (2002) 771-777
4. Rucker D., Allan J.A., Fick G.H., and Hanley D.A. Vitamin D insufficiency in a population of healthy western Canadians. Can Med Assoc J 166 (2002) 1517-1524
5. Nesby-O'Dell S., Scanlon K.S., Cogswell M.E., et al. Hypovitaminosis D prevalence and determinants among African American and white women of reproductive age: third National Health and Nutrition Examination Survey, 1988-1994. Am J Clin Nutr 76 (2002) 187-192
6. Calvo M.S., and Whiting S.J. Prevalence of vitamin D insufficiency in Canada and the United States: importance to health status and efficacy of current food fortification and dietary supplement use. Nutr Rev 61 (2003) 107-113
7. Holick M.F. Vitamin D deficiency. N Engl J Med 357 (2007) 266-281
8. Binkley N. Does low vitamin D status contribute to "age-related" morbidity?. J Bone Miner Res 22 (2007) V55-V58
9. DeLuca H.F. The vitamin D story: a collaborative effort of basic science and clinical medicine. FASEB J 2 (1988) 224-236
10. Standing Committee on the Scientific Evaluation of Dietary Reference Intakes Food and Nutrition Board, Institute of Medicine. DRI Dietary Reference Intakes for calcium phosphorus, magnesium, vitamin D and fluoride (1997), National Academy Press, Washington, DC
11. Hollis B.W., and Horst R.L. The assessment of circulating 25(OH)D and 1, 25 (OH)2D: where we are and where we are going. J Steroid Biochem Mol Biol 103 (2007) 473-476
12. 3 in humans. J Clin Endocrinol Metab 89 (2004) 5387-5391
13. 2) as a vitamin supplement. Am J Clin Nutr 84 (2006) 694-697
14. 3 in maintaining circulating concentrations of 25-hydroxyvitamin D. J Clin Endocrinol Metab 93 (2008) 677-681
15. Glendenning P., Seymour H., Gillett M.J., et al. Ergocalciferol is not bioequivalent to cholecalciferol in vitamin D insufficient hip fracture cases. J Bone Miner Res 23 Suppl (2008) S81
16. Anonymous Vitamin D deficiency: informationfor cancer patients. 2008 (Accessed: October 24, 2008, Available at: www.boneandcancerfoundation.org).
17. Holick M.F. Too little vitamin D in premenopausal women: why should we care?. Am J Clin Nutr 76 (2002) 3-4
18. Giovannucci E. Can vitamin D reduce total mortality?. Arch Intern Med 167 (2007) 1709-1710
19. Anonymous. 2007 Annual report of the boards of trustees of the federal hospital insurance and federal supplementary medical insurance trust funds. (Accessed: October 23, 2008, Available at: www.cms.hhs.gov/reportstrustfunds/downloads/tr2007.pdf).
20. 3 intake for the elderly. J Nutr 136 (2006) 1123-1125
21. 3 supplementation on serum 25OHD. J Bone Miner Res 23 Suppl 1 (2008) S350
22. 3. J Clin Invest 76 (1985) 1536-1538
23. Weaver C.M., and Fleet J.C. Vitamin D requirements: current and future. Am J Clin Nutr 80 6 Suppl (2004) 1735S-1739S
24. Matsuoka L.Y., Wortsman J., Haddad J.G., et al. Racial pigmentation and the cutaneous synthesis of vitamin D. Arch Dermatol 127 (1991) 536-538
25. Haddad J.G., and Chyu K.J. Competitive protein-binding radioassay for 25-hydroxycholecalciferol. J Clin Endocrinol Metab 33 (1971) 992-995
26. Belsey R., DeLuca H., and Potts J. Competitive binding assay for vitamin D and 25-OH vitamin D. J Clin Endocrinol Metab 33 (1971) 554-557
27. Hollis B.W., and Napoli J.L. Improved radioimmunoassay for vitamin D and its use in assessing vitamin D status. Clin Chem 31 (1985) 1815-1819
28. Gamma B 25-hydroxy vitamin D RIA [package insert] (2005), IDA Ltd, Boldon, UK
29. 3 on the Roche modular E170 analyzer. Clin Chem 54 (2008) 1-4
30. Caldwell R.D., Porteous C.E., Trafford D.J., and Makin H.L. Gas chromatography-mass spectrometry and the measurement of vitamin D metabolites in human serum or plasma. Steroids 49 (1987) 155-196
31. Seamark D.A., Trafford D.J., and Makin H.L. The estimation of vitamin D and some metabolites in human plasma by mass fragmentography. Clin Chim Acta 106 (1980) 51-62
32. 3 in plasma using high-pressure liquid chromatography. Anal Biochem 90 (1977) 298-305
33. Turpeinen U., Hohenthal U., and Stenman U.H. Determination of 25-hydroxyvitamin D in serum by HPLC and immunoassay. Clin Chem 49 (2003) 1521-1524
34. Lensmeyer G.L., Wiebe D.A., Binkley N., and Drezner M.K. Measurement of 25-hydroxyvitamin D revisited: reply to letter. Clin Chem 52 (2006) 2305-2306
35. 3. Clin Chem 51 (2005) 1683-1690
36. 3 by liquid chromatography tandem-mass spectrometry. Clin Chem 50 (2004) 1415-1417
37. Chen H., McCoy L.F., Schleichter R.L., and Pfeiffer C.M. Measurement of 25-hydroxyvitamin D3 (25OHD3) and 25-hydroxyvitamin D2 (25OHD2) in human serum using liquid chromatography-tandem mass spectrometry and its comparison to a radioimmunoassay method. Clin Chim Acta 391 (2008) 6-12
38. Singh R., Taylor R., Reddy R., et al. C-3 epimers can account for a significant portion of total circulating 25-hydroxyvitamin D in infants, complicating accurate measurement and interpretation of vitamin D status. J Clin Endocrinol Metab 91 (2006) 3055-3061
39. Lensmeyer G.L., Wiebe D.A., Binkley N., and Drezner M.K. HPLC method for 25-hydroxyvitamin D measurement: comparison with contemporary assays. Clin Chem 52 (2006) 1120-1126
40. 2. Am J Clin Nutr 68 (1998) 854-858
41. Stenman U.H. Immunoassay standardization: is it possible, who is responsible, who is capable?. Clin Chem 47 (2001) 815-820
42. Valdes R.J., and Jortani S. Unexpected suppression of immunoassay results by cross-reactivity: now a demonstrated cause for concern. Clin Chem 48 (2002) 405-406
43. Roth H.J., Schmidt-Gayk H., Weber H., and Niederau C. Accuracy and clinical implications of seven 25-hydroxyvitamin D methods compared with liquid chromatography-tandem mass spectrometry as a reference. Ann Clin Biochem 45 (2008) 153-159
44. 2 compared with HPLC: need for assay-specific decision limits and metabolite-specific assays. Ann Clin Biochem 43 (2006) 23-30
45. Hollis B.W. Assessment of vitamin D status and definition of a normal circulating range of 25-hydroxyvitamin D. Curr Opin Endocrinol Diab Obes 15 (2008) 489-494
46. Ramakkrishnan K., and Holick M.F. Underestimation of 25-OHvitamin D by Nichols Advantage Assay in patients receiving vitamin D replacement therapy. Clin Chem 51 (2005) 1074
47. Cavalier E., Wallace A.M., Knox S., et al. Serum vitamin D measurement may not reflect what you give to your patients. J Bone Miner Res 23 (2008) 1864-1865
48. Lensmeyer G.L., Binkley N., and Drezner M.K. New horizons for assessment of vitamin D status in man. In: Bilezikian J.P. (Ed). Dynamics of bone and cartilage metabolism principles and clinical applications. 2nd ed (2006), Academic Press, San Diego 513-528
49. Healy M.J.R. Outliers in clinical chemistry quality-control schemes. Clin Chem 25 (1979) 675-677
50. Binkley N. Vitamin D: clinical measurement and use. J Musculoskelet Neuronal Interact 6 (2006) 338-340
51. Binkley N., Novotny R., Krueger D., et al. Low vitamin D status despite abundant sun exposure. J Clin Endocrinol Metab 92 (2007) 2130-2135
52. Phinney K.W. Development of a standard reference material for vitamin D in serum. Am J Clin Nutr 88 Suppl (2008) 511S-512S
53. Binkley N., Krueger D., Engelke J.A., and Drezner M.K. What is your patient's vitamin D status? Clinical consideration of variability in a 25(OH)D measurement. J Bone Miner Res 23 Suppl 1 (2008) S351
54. Rejnmark L., Lauridsen A.L., Brot C., et al. Vitamin D and its binding protein Gc: long-term variability in peri- and postmenopausal women with and without hormone replacement therapy. Scand J Clin Lab Invest 66 (2006) 227-238
55. Lester E., Skinner R.K., and Wills M.R. Seasonal variation in serum 25-hydroxyvitamin D in the elderly in Britain. Lancet 1 (1977) 979-980
56. Dawson-Hughes B., Heaney R.P., Holick M.F., et al. Estimates of optimal vitamin D status. Osteoporos Int 16 (2005) 713-716
57. Lips P. Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev 22 (2001) 477-501
58. Vieth R. Vitamin D toxicity, policy and science. J Bone Miner Res 22 Suppl 2 (2007) V64-V68
59. Vieth R. Vitamin D supplementation, 25-hydroxyvitamin D concentrations and safety. Am J Clin Nutr 69 (1999) 842-856
60. Hollis B.W. Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: implications for establishing a new effective dietary intake recommendation for vitamin D. J Nutr 135 (2005) 317-322
61. Barger-Lux M.J., and Heaney R.P. Effects of above average summer sun exposure on serum 25-hydroxyvitamin D and calcium absorption. J Clin Endocrinol Metab 87 (2002) 4952-4956
62. Binkley N., Drezner M.K., and Hollis B.W. Laboratory reporting of 25-hydroxyvitamin D results: potential for clinical misinterpretation. Clin Chem 52 (2006) 2124-2125
63. Bischoff-Ferrari H.A., Giovannucci E., Willett W.C., et al. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 84 (2006) 18-28
64. Binkley N., Krueger D., Lensmeyer G.L., et al. Is clinical measurement of 25-hydroxyvitamin D still a problem?. Osteoporos Int 20 Suppl 2 (2009) S202
65. Tangpricha V., Turner A., Spina C., et al. Tanning is associated with optimal vitamin D status (serum 25-hydroxyvitamin D concentration) and higher bone mineral density. Am J Clin Nutr 80 (2004) 1645-1649
66. Heaney R.P. Nutrition and chronic disease. Mayo Clin Proc 81 (2006) 297-299
67. Lowe H., Binkley N., Blaner W.S., et al. Vitamin D toxicity due to a commonly available remedy from the Dominican Republic. J Bone Miner Res 23 Suppl 1 (2008) S288
68. Pepper K.J., Judd S.E., Nanes M.S., and Tangpricha V. Evaluation of vitamin D repletion regimens to correct vitamin D status in adults. Endocr Pract 15 (2009) 95-103
69. Przybelski R., Agrawal S., Krueger D., et al. Rapid correction of low vitamin D status in nursing home residents. Osteoporos Int 19 (2008) 1621-1628
70. Malabanan A., Veronikis I.E., and Holick M.F. Redefining vitamin D insufficiency. Lancet 351 9105 (1998) 805-806
71. Heaney R.P., Davies K.M., Chen T.C., et al. Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr 77 (2003) 204-210
72. Hollis B.W. Measuring 25-hydroxyvitamin D in a clinical environment: challenges and needs. Am J Clin Nutr 88 Suppl (2008) 507S-510S